Current Environment: Production

Medical Services

Specialties

Programs & Services

Languages

  • English

Education

Undergraduate School

Hanover College

2002, Hanover, IN

Medical School

University of Cincinnati Medical School

2006, Cincinnati, OH

Internship

Pediatrics

Cincinnati Children's Hospital Medical Center

2007, Cincinnati, OH

Residency

Pediatric Neurology

Cincinnati Children's Hospital Medical Center

2011, Cincinnati, OH

Fellowship

Cerebrovascular and Stroke

Boston Children's Hospital

2013, Boston, MA

Graduate School

Harvard T. H. Chan School of Public Health

2021, Boston, MA

Certifications

  • American Board of Psychiatry and Neurology (Child and Adolescent Neurology)

Professional History

I am a child neurologist with special interest in cerebrovascular disorders, stroke, and neurocritical care. Currently I am involved in the inpatient Intensive Care Neurology Service, inpatient and outpatient for the Stroke and Cerebrovascular Center, and outpatient general neurology clinics.  I serve as the Outpatient Medical Director for the Stroke and Cerebrovascular Center that focuses on a multidisciplinary approach to optimize diagnosis and treatment.

My current research also focuses on cerebrovascular disorders and stroke with specific focus on risk factors in both perinatal and childhood stroke and emotional outcomes of parents and children following pediatric stroke.

Media

Caregiver Profile

Meet Dr. Laura Lehman

Publications

  1. Moyamoya Across the Lifespan: Current Neurologic Care and Future Directions. Neurology. 2025 Apr 08; 104(7):e213484. View Abstract

  2. Survival machine learning methods for mortality prediction after heart transplantation in the contemporary era. PLoS One. 2025; 20(1):e0313600. View Abstract

  3. Otitic hydrocephalus and papilloedema-re-evaluating a treatment paradigm. Eye (Lond). 2025 Mar; 39(4):741-747. View Abstract

  4. Reply to "Letter to the editor: Incidence of de novo malignancy and all-cause mortality among heart transplant recipients". Int J Cardiol. 2025 Jan 15; 419:132691. View Abstract

  5. Symptoms Do Not Predict White Matter Injury in the Watershed Regions in Children with Moyamoya. J Pediatr. 2025 Jan; 276:114372. View Abstract

  6. Trends in the Diagnosis of Pediatric Venous Thromboembolism and Arterial Ischemic Stroke during the COVID-19 Pandemic: An Administrative Database Study. J Pediatr. 2025 Jan; 276:114328. View Abstract

  7. Incidence of de novo malignancy and all-cause mortality among heart transplant recipients. Int J Cardiol. 2024 Nov 15; 415:132455. View Abstract

  8. Magnetic Resonance Angiography Alone Is Insufficient for Diagnosis and Surgical Planning in Children With Moyamoya. Pediatr Neurol. 2024 Oct; 159:1-3. View Abstract

  9. Prevention of postoperative stroke in pediatric moyamoya patients: a standardized perioperative care protocol. J Neurosurg Pediatr. 2024 Feb 01; 33(2):185-189. View Abstract

  10. Cerebral Vasculopathy in Children with Neurofibromatosis Type 1. Cancers (Basel). 2023 Oct 23; 15(20). View Abstract

  11. Yield of genetic evaluation in non-syndromic pediatric moyamoya patients. Childs Nerv Syst. 2024 Mar; 40(3):801-808. View Abstract

  12. Autism Spectrum Disorder in Children With Perinatal Ischemic Stroke Varies by Stroke Type. J Child Neurol. 2023 08; 38(8-9):513-517. View Abstract

  13. Pediatric Moyamoya Revascularization Perioperative Care: A Modified Delphi Study. Neurocrit Care. 2024 Apr; 40(2):587-602. View Abstract

  14. Neurosurgical outcomes of pediatric cerebral venous sinus thrombosis following acute mastoiditis: a systematic review and meta-analysis. J Neurosurg Pediatr. 2023 07 01; 32(1):60-68. View Abstract

  15. Diffusion-Weighted Magnetic Resonance Imaging Demonstrates White Matter Alterations in Watershed Regions in Children With Moyamoya Without Stroke or Silent Infarct. Pediatr Neurol. 2023 06; 143:89-94. View Abstract

  16. Racial disparities in post-transplant stroke and mortality following stroke in adult cardiac transplant recipients in the United States. PLoS One. 2023; 18(2):e0268275. View Abstract

  17. Pediatric Moyamoya Syndrome Secondary to Tuberculous Meningitis: A Case Report. Neurol Clin Pract. 2023 Feb; 13(1):e200121. View Abstract

  18. Closing the Gap in Pediatric Hemorrhagic Stroke: A Systematic Review. Semin Pediatr Neurol. 2022 10; 43:101001. View Abstract

  19. Pediatric Moyamoya Biomarkers: Narrowing the Knowledge Gap. Semin Pediatr Neurol. 2022 10; 43:101002. View Abstract

  20. Racial and Ethnic Disparities in Incidence and Prognosis of Perioperative Stroke Among Pediatric Cardiac Transplant Recipients. J Am Heart Assoc. 2022 07 19; 11(14):e025149. View Abstract

  21. Post-transplant mortality and graft failure after induction immunosuppression among Black heart transplant recipients in the United States. Am J Transplant. 2022 11; 22(11):2586-2597. View Abstract

  22. Pediatric Ischemic Stroke: An Infrequent Complication of SARS-CoV-2. Ann Neurol. 2021 04; 89(4):657-665. View Abstract

  23. Adverse effects of erenumab on cerebral proliferative angiopathy: A case report. Cephalalgia. 2021 01; 41(1):122-126. View Abstract

  24. Prevalence of Symptoms of Anxiety, Depression, and Post-traumatic Stress Disorder in Parents and Children Following Pediatric Stroke. J Child Neurol. 2020 06; 35(7):472-479. View Abstract

  25. Serial vessel wall MR imaging of pediatric tuberculous vasculitis. Neurol Clin Pract. 2019 Dec; 9(6):459-461. View Abstract

  26. Characteristics and Outcome in Children With Craniectomy Following Acute Ischemic Stroke in the International Pediatric Stroke Study. J Child Neurol. 2019 10; 34(12):765-769. View Abstract

  27. What Will Improve Pediatric Acute Stroke Care? Stroke. 2019 02; 50(2):249-256. View Abstract

  28. Pediatric Stroke Rates Over 17 Years: Report From a Population-Based Study. J Child Neurol. 2018 06; 33(7):463-467. View Abstract

  29. Placental Pathology in Neonatal Stroke: A Retrospective Case-Control Study. J Pediatr. 2018 04; 195:39-47.e5. View Abstract

  30. Workup for Perinatal Stroke Does Not Predict Recurrence. Stroke. 2017 08; 48(8):2078-2083. View Abstract

  31. Transient Focal Neurologic Symptoms Correspond to Regional Cerebral Hypoperfusion by MRI: A Stroke Mimic in Children. AJNR Am J Neuroradiol. 2017 Nov; 38(11):2199-2202. View Abstract

  32. Pathways for Neuroimaging of Neonatal Stroke. Pediatr Neurol. 2017 04; 69:37-48. View Abstract

  33. Pathways for Neuroimaging of Childhood Stroke. Pediatr Neurol. 2017 04; 69:11-23. View Abstract

  34. Cerebrovascular Complications of Pediatric Pneumococcal Meningitis in the PCV13 Era. Hosp Pediatr. 2016 Jun; 6(6):374-9. View Abstract

  35. Predictors of Stroke After Transient Ischemic Attack in Children. Stroke. 2016 Jan; 47(1):88-93. View Abstract

  36. Perinatal arterial ischemic stroke: presentation, risk factors, evaluation, and outcome. Pediatr Neurol. 2014 Dec; 51(6):760-8. View Abstract

  37. Changing ethnic disparity in ischemic stroke mortality in US children after the STOP trial. JAMA Pediatr. 2013 Aug 01; 167(8):754-8. View Abstract

  38. Leukoaraiosis and sex predict the hyperacute ischemic core volume. Stroke. 2013 Jan; 44(1):61-7. View Abstract

  39. Vertebral artery dissection leading to stroke caused by violent neck tics of Tourette syndrome. Neurology. 2011 Nov 01; 77(18):1706-8. View Abstract

  40. Potential eligibility for recombinant tissue plasminogen activator therapy in children: a population-based study. J Child Neurol. 2011 Sep; 26(9):1121-5. View Abstract

  41. Menstrual migraine in adolescents. Headache. 2009 Mar; 49(3):341-7. View Abstract